Ten years of change in clinical disease status and treatment in rheumatoid arthritis: results based on standardized monitoring of patients in an ordinary outpatient clinic in southern Norway

Physicians' adherence to tight control treatment strategy and combination DMARD therapy are additively important for reaching remission and maintaining working ability in early rheumatoid arthritis: a subanalysis of the FIN-RACo trial

(2013) Vappu Rantalaiho et al.   ANNALS OF THE RHEUMATIC DISEASES

Time trends in disease activity, response and remission rates in rheumatoid arthritis during the past decade: results from the NOR-DMARD study 2000–2010

(2013) Anna-Birgitte Aga et al.   ANNALS OF THE RHEUMATIC DISEASES

Biologic registries in rheumatology: Lessons learned and expectations for the future

(2012) Ori Elkayam et al.   AUTOIMMUNITY REVIEWS

American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials

(2011) David T. Felson et al.   ARTHRITIS AND RHEUMATISM

Treating rheumatoid arthritis to target: recommendations of an international task force

(2010) J. S. Smolen et al.   ANNALS OF THE RHEUMATIC DISEASES

Changes in disease characteristics and response rates among patients in the United Kingdom starting anti-tumour necrosis factor therapy for rheumatoid arthritis between 2001 and 2008

(2010) K. L. Hyrich et al.   RHEUMATOLOGY

DANBIO--powerful research database and electronic patient record

(2010) M. L. Hetland   RHEUMATOLOGY

Rheumatoid arthritis: strategy more important than agent

(2009) Tuulikki Sokka et al.   LANCET

Do changes in prescription practice in patients with rheumatoid arthritis treated with biological agents affect treatment response and adherence to therapy? Results from the nationwide Danish DANBIO Registry

(2008) M L Hetland et al.   ANNALS OF THE RHEUMATIC DISEASES